PetCaseFinder

Peer-reviewed veterinary case report

Heart risk levels in dogs with early mitral valve disease

By Vezzosi, Tommaso et al.·Published in Journal of veterinary internal medicine·2025·Department of Veterinary Sciences, Italy·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Risk Stratification Using Mitral INsufficiency Echocardiographic Score 2 in Dogs With Preclinical Mitral Valve Disease.

Species:
dog

Plain-English summary

A study involving 749 dogs with early signs of mitral valve disease (a common heart issue in dogs) found that a simplified scoring system called the MINE score can help predict the risk of heart problems. The research showed that dogs with mild cases had a longer time before experiencing serious heart issues, while those with severe cases faced problems much sooner. This scoring system can assist veterinarians in determining how advanced a dog's heart condition is and guide treatment decisions. If your dog has been diagnosed with mitral valve disease, discussing the MINE score with your vet could be beneficial for understanding their condition and planning for the future.

Abstract

BACKGROUND: Outcome-based cardiac risk stratification schemes are lacking for preclinical myxomatous mitral valve disease (MMVD). The Mitral INsufficiency Echocardiographic (MINE) score was developed as an easy-to-use severity classification of MMVD. HYPOTHESIS/OBJECTIVES: The primary aim was to verify the efficacy of the MINE score in stratifying the cardiac risk in preclinical MMVD. Secondary aims were to evaluate a simplification of the original score and propose a definition of "advanced B2". ANIMALS: Seven hundred forty-nine dogs with preclinical MMVD. METHODS: Retrospective, multicenter, cohort study. Clinical usefulness of the MINE score was tested by evaluating its association with median time to cardiac event. The Cox proportional hazards regression was used to evaluate the echocardiographic independent predictors of cardiac endpoint. Long-term outcome was analyzed using Kaplan-Meier curves and log-rank test. RESULTS: Based on multivariate analysis, a simplified version of the MINE score was redefined including only the left atrium-to-aorta ratio, the left ventricular end-diastolic diameter, and the E-wave velocity. Mild cases had longer median time to cardiac event [2604&#x2009;days, 95% confidence interval (CI) 2344-2604&#x2009;days] in comparison to moderate (1216&#x2009;days, 95% CI 998-1882&#x2009;days) and severe cases (718&#x2009;days, 95% CI 599-980&#x2009;days; p&#x2009;<&#x2009;0.001). Among stage B2, severe cases had shorter median time to cardiac event (718&#x2009;days, 95% CI 599-980&#x2009;days) in comparison to moderate (1141&#x2009;days, 95% CI 980-1725&#x2009;days) and mild cases (not available; p&#x2009;<&#x2009;0.001). CONCLUSIONS AND CLINICAL IMPORTANCE: For this study cohort, the simplified version of the MINE score was clinically effective for risk stratification of preclinical MMVD. Dogs in stage B2 classified as "severe" can be defined "advanced" B2.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40865020/